Skip to main content

Table 2 Postoperative outcomes: effects of perioperative statin therapy versus control

From: Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials

Postoperative outcome

Number of trials

Number of patients

OR (95% CI)

P value

Trial sequential analysis

Level of evidence

Acute kidney injury

 Trials with low risk of bias

3

2637

1.26 (1.05, 1.52)

0.01

Conclusive: harmful of statins

High

 All trials

10

3354

1.18 (0.99, 1.41)a

0.06

Inconclusive

Low

Atrial fibrillation

 Trials with low risk of bias

2

2537

1.08 (0.90, 1.30)

0.40

Conclusive: futility of statins

Moderate

 All trials

19

4737

0.80 (0.70, 0.91)a

0.001

Inconclusive

Very low

Myocardial infarction

 Trials with low risk of bias

2

2537

0.97 (0.71, 1.33)

0.87

Conclusive: futility of statins

Moderate

 All trials

18

4151

0.92 (0.69, 1.23)a

0.56

Conclusive: futility of statins

Very low

Stroke

 Trials with low risk of bias

2

2537

1.25 (0.58, 2.70)

0.56

Conclusive: futility of statins

Low

 All trials

11

3499

1.09 (0.60, 2.00)

0.77

Conclusive: futility of statins

Very low

Infections

 Trials with low risk of bias

2

2537

0.80 (0.60, 1.07)

0.14

Inconclusive

Low

 All trials

7

2724

0.78 (0.59, 1.04)

0.09

Conclusive: futility of statins

Very low

Mortality

 Trials with low risk of bias

3

2637

3.84 (0.95, 15.55)

0.06

Inconclusive

Low

 All trials

18

4157

1.92 (0.79, 4.66)

0.15

Inconclusive

Very low

  1. aEvidence of publication bias in favor of statins. Italics indicate statistical significance. OR odds ratio, CI confidence interval